The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 08, 2025

Filed:

Mar. 31, 2020
Applicant:

Huabo Biopharm (Shanghai) Co., Ltd., Shanghai, CN;

Inventors:

Xiangyang Zhu, Shanghai, CN;

Fengxue Zhang, Shanghai, CN;

Mingqing Cai, Shanghai, CN;

Lei Zhang, Shanghai, CN;

Shi Chen, Shanghai, CN;

Ling Yu, Shanghai, CN;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61K 47/68 (2017.01); A61P 35/00 (2006.01); C07K 16/22 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2827 (2013.01); A61K 47/6879 (2017.08); A61P 35/00 (2018.01); C07K 16/22 (2013.01); A61K 2039/505 (2013.01); C07K 2317/31 (2013.01); C07K 2317/92 (2013.01);
Abstract

The present invention provides an anti-PD-L1/VEGF bispecific antibody and a use thereof. Specifically, the present invention provides a bifunctional antibody, comprising: (a) anti-PD-L1 antibody or element; and (b) an anti-VEGF antibody or element linked to the anti-PD-L1 antibody or element. The bifunctional antibody of the present invention can simultaneously bind to VEGF and PD-L1, thereby exerting a therapeutic effect on VEGF and PD-L1-positive tumor cells (especially malignant tumor cells).


Find Patent Forward Citations

Loading…